comparemela.com

Latest Breaking News On - Clinical genomics - Page 12 : comparemela.com

Mesa Laboratories, Inc to Announce Second Quarter Results on November 6, 2023

Mesa Laboratories, Inc to Announce Second Quarter Results on November 6, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

John sakysGary owensBiopharmaceutical developmentMesa laboratories incCalibration solutionsMesa laboratoriesDisinfection controlClinical genomics

Mesa Laboratories, Inc to Announce Second Quarter Results on November 6, 2023

LAKEWOOD, Colo., Sept. 13, 2023 Mesa Laboratories, Inc. will issue a press release with financial results for the second quarter of fiscal year 2024 at approximately 8:00 A.M. Eastern time on.

Calibration solutionsMesa laboratories incBiopharmaceutical developmentMesa laboratoriesDisinfection controlClinical genomics

Mesa Laboratories, Inc to Announce Second Quarter Results on November 6, 2023

13.09.2023 - LAKEWOOD, Colo., Sept. 13, 2023 (GLOBE NEWSWIRE) - Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the second quarter of fiscal year 2024 at approximately 8:00 A.M. Eastern time on Monday, November 6, .

Gary owensJohn sakysCalibration solutionsBiopharmaceutical developmentMesa laboratories incDisinfection controlClinical genomicsMesa laboratories

Insider Selling: Mesa Laboratories, Inc (NASDAQ:MLAB) CEO Sells $285,640 00 in Stock

Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) CEO Gary M. Owens sold 2,000 shares of the business’s stock in a transaction dated Friday, September 1st. The shares were sold at an average price of $142.82, for a total transaction of $285,640.00. Following the transaction, the chief executive officer now directly owns 30,032 shares in […]

Hong kongUnited statesGarym owensAsia pacificCalibration solutionsBiopharmaceutical developmentMesa laboratories company profileHong kong ltdMesa laboratories incGlobal retirement partnersTower research capitalMesa laboratoriesGet free reportLaboratories stock downKong ltdZentral genossenschafts bank frankfurt

NovaSeq™ 6000Dx sequencing instrument : Get Quote, RFQ, Price or Buy

The NovaSeq™ 6000Dx is Illumina’s first IVD-compliant high-throughput sequencing instrument for the clinical lab. Push the boundaries of clinical genomics with scalable throughput and improved economics like never before.

Illumina incClinical genomics

vimarsana © 2020. All Rights Reserved.